MicroRNAs in diseases: From candidate to modifier genes

Clinical Genetics

Volumn 77, Issue 4, 2010, Pages 306-313

  Bandiera, S ^a   Hatem, E ^a   Lyonnet, S ^a   Henrion Caude, A ^a  

^a INSERM   (France)

Author keywords

Computational tools; Copy number variation; Genetic diseases; MicroRNA; Polymorphism

Indexed keywords

MICRORNA;

3' UNTRANSLATED REGION; BINDING SITE; CONGENITAL HEART DISEASE; COPY NUMBER VARIATION; FRONTOTEMPORAL DEMENTIA; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HEREDITARY MOTOR SENSORY NEUROPATHY; HETEROZYGOSITY LOSS; HUMAN; LOSS OF FUNCTION MUTATION; MONOGENIC DISORDER; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; PARKINSON DISEASE; POINT MUTATION; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SUPPORT VECTOR MACHINE;

COMPUTATIONAL BIOLOGY; DISEASE; DNA COPY NUMBER VARIATIONS; GENETIC DISEASES, INBORN; HUMANS; MICRORNAS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 77951701375     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2010.01370.x     Document Type: Review

References (78)

1. Szulwach KE, Jin P, Alisch RS. Noncoding RNAs in mental retardation. Clin Genet 2009, 75:209-219.
2. Carninci P, Kasukawa T, Katayama S. The transcriptional landscape of the mammalian genome. Science 2005
3. Kapranov P, Drenkow J, Cheng J. Examples of the complex architecture of the human transcriptome revealed by RACE and high-density tiling arrays. Genome Res 2005, 15:987-997.
4. Mattick JS. The genetic signatures of noncoding RNAs. PLoS Genet 2009, 5:e1000459.
5. Mattick JS, Makunin IV. Non-coding RNA. Hum Mol Genet 2006, 15(Suppl. 1):R17-R29.
6. Kapranov P, Willingham AT, Gingeras TR. Genome-wide transcription and the implications for genomic organization. Nat Rev Genet 2007, 8:413-423.
7. Bartel DP, Chen CZ. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet 2004, 5:396-400.
8. Griffiths-Jones S, Saini HK, van Dongen S. miRBase: tools for microRNA genomics. Nucleic Acids Res 2008, 36:D154-D158.
9. Muinos-Gimeno M, Montfort M, Bayes M. Design and evaluation of a panel of single-nucleotide polymorphisms in microRNA genomic regions for association studies in human disease. Eur J Hum Genet 2009, October 7. [Epub ahead of print].
10. Calin GA, Sevignani C, Dumitru CD. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 2004, 101:2999-3004.
11. Calin GA, Croce CM. Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications. J Clin Invest 2007, 117:2059-2066.
12. Lee Y, Kim M, Han J. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004, 23:4051-4060.
13. Lee Y, Jeon K, Lee JT. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J 2002, 21:4663-4670.
14. Lee Y, Ahn C, Han J. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003, 425:415-419.
15. Cai X, Hagedorn CH, Cullen BR. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 2004, 10:1957-1966.
16. Yi R, Qin Y, Macara IG. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 2003, 17:3011-3016.
17. Chendrimada TP, Gregory RI, Kumaraswamy E. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 2005, 436:740-744.
18. Schwarz DS, Hutvagner G, Du T. Asymmetry in the assembly of the RNAi enzyme complex. Cell 2003, 115:199-208.
19. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
20. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 2008, 9:102-114.
21. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006, 6:259-269.
22. Griffiths-Jones S, Grocock RJ, van Dongen S. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006, 34:D140-D144.
23. Georges M, Clop A, Marcq F. Polymorphic microRNA-target interactions: a novel source of phenotypic variation. Cold Spring Harb Symp Quant Biol 2006, 71:343-350.
24. Lim LP, Lau NC, Weinstein EG. The microRNAs of Caenorhabditis elegans. Genes Dev 2003, 17:991-1008.
25. Nam JW, Shin KR, Han J. Human microRNA prediction through a probabilistic co-learning model of sequence and structure. Nucleic Acids Res 2005, 33:3570-3581.
26. Friedlander MR, Chen W, Adamidi C. Discovering microRNAs from deep sequencing data using miRDeep. Nat Biotechnol 2008, 26:407-415.
27. Wang X, Zhang J, Li F. MicroRNA identification based on sequence and structure alignment. Bioinformatics 2005, 21:3610-3614.
28. Sethupathy P, Megraw M, Hatzigeorgiou AG. A guide through present computational approaches for the identification of mammalian microRNA targets. Nat Methods 2006, 3:881-886.
29. Miranda KC, Huynh T, Tay Y. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 2006, 126:1203-1217.
30. Yang Y, Wang YP, Li KB. MiRTif: a support vector machine-based microRNA target interaction filter. BMC Bioinformatics 2008, 9(Suppl. 12):S4.
31. Mencia A, Modamio-Hoybjor S, Redshaw N. Mutations in the seed region of human miR-96 are responsible for nonsyndromic progressive hearing loss. Nat Genet 2009, 41:609-613.
32. Modamio-Hoybjor S, Moreno-Pelayo MA, Mencia A. A novel locus for autosomal dominant nonsyndromic hearing loss, DFNA50, maps to chromosome 7q32 between the DFNB17 and DFNB13 deafness loci. J Med Genet 2004, 41:e14.
33. Weston MD, Pierce ML, Rocha-Sanchez S. MicroRNA gene expression in the mouse inner ear. Brain Res 2006, 1111:95-104.
34. Lewis MA, Quint E, Glazier AM. An ENU-induced mutation of miR-96 associated with progressive hearing loss in mice. Nat Genet 2009, 41:614-618.
35. Abelson JF, Kwan KY, O'Roak BJ. Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 2005, 310:317-320.
36. Scharf JM, Moorjani P, Fagerness J. Lack of association between SLITRK1var321 and Tourette syndrome in a large family-based sample. Neurology 2008, 70:1495-1496.
37. Pasquini M, Fabbrini G, Berardelli I. Psychopathological features of obsessive-compulsive disorder in an Italian family with Gilles de la Tourette syndrome not linked to the SLITRK1 gene. Psychiatry Res 2008, 161:109-111.
38. Stillman AA, Krsnik Z, Sun J. Developmentally regulated and evolutionarily conserved expression of SLITRK1 in brain circuits implicated in Tourette syndrome. J Comp Neurol 2009, 513:21-37.
39. Miranda DM, Wigg K, Kabia EM. Association of SLITRK1 to Gilles de la Tourette Syndrome. Am J Med Genet B Neuropsychiatr Genet 2009, 150B:483-486.
40. Zuchner S, Wang G, Tran-Viet KN. Mutations in the novel mitochondrial protein REEP1 cause hereditary spastic paraplegia type 31. Am J Hum Genet 2006, 79:365-369.
41. Beetz C, Schule R, Deconinck T. REEP1 mutation spectrum and genotype/phenotype correlation in hereditary spastic paraplegia type 31. Brain 2008, 131:1078-1086.
42. Lin CH, Li LH, Ho SF. A large-scale survey of genetic copy number variations among Han Chinese residing in Taiwan. BMC Genet 2008, 9:92.
43. Wong KK, deLeeuw RJ, Dosanjh NS. A comprehensive analysis of common copy-number variations in the human genome. Am J Hum Genet 2007, 80:91-104.
44. Sonoki T, Iwanaga E, Mitsuya H. Insertion of microRNA-125b-1, a human homologue of lin-4, into a rearranged immunoglobulin heavy chain gene locus in a patient with precursor B-cell acute lymphoblastic leukemia. Leukemia 2005, 19:2009-2010.
45. Duan S, Mi S, Zhang W. Comprehensive analysis of the impact of SNPs and CNVs on human microRNAs and their regulatory genes. RNA Biol 2009, 6:412-425.
46. Pasmant E, de Saint-Trivier A, Laurendeau I. Characterization of a 7.6-Mb germline deletion encompassing the NF1 locus and about a hundred genes in an NF1 contiguous gene syndrome patient. Eur J Hum Genet 2008, 16:1459-1466.
47. Calin GA, Dumitru CD, Shimizu M. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002, 99:15524-15529.
48. Drake KM, Ruteshouser EC, Natrajan R. Loss of heterozygosity at 2q37 in sporadic Wilms' tumor: putative role for miR-562. Clin Cancer Res 2009, 15:5985-5992.
49. Bousquet M, Quelen C, Rosati R. Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation. J Exp Med 2008, 205:2499-2506.
50. Wang Y, Liang Y, Lu Q. MicroRNA epigenetic alterations: predicting biomarkers and therapeutic targets in human diseases. Clin Genet 2008, 74:307-315.
51. Iwai N, Naraba H. Polymorphisms in human pre-miRNAs. Biochem Biophys Res Commun 2005, 331:1439-1444.
52. Hu Z, Chen J, Tian T. Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest 2008, 118:2600-2608.
53. Peng S, Kuang Z, Sheng C. Association of MicroRNA-196a-2 gene polymorphism with gastric cancer risk in a Chinese population. Dig Dis Sci 2009, October 16. [Epub ahead of print].
54. Xu J, Hu Z, Xu Z. Functional variant in microRNA-196a2 contributes to the susceptibility of congenital heart disease in a Chinese population. Hum Mutat 2009, 30:1231-1236.
55. Sun G, Yan J, Noltner K. SNPs in human miRNA genes affect biogenesis and function. RNA 2009, 15:1640-1651.
56. Jazdzewski K, Liyanarachchi S, Swierniak M. Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer. Proc Natl Acad Sci U S A 2009, 106:1502-1505.
57. Quach H, Barreiro LB, Laval G. Signatures of purifying and local positive selection in human miRNAs. Am J Hum Genet 2009, 84:316-327.
58. Hariharan M, Scaria V, Brahmachari SK. dbSMR: a novel resource of genome-wide SNPs affecting microRNA mediated regulation. BMC Bioinformatics 2009, 10:108.
59. Bao L, Zhou M, Wu L. PolymiRTS Database: linking polymorphisms in microRNA target sites with complex traits. Nucleic Acids Res 2007, 35:D51-D54.
60. Martin MM, Buckenberger JA, Jiang J. The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microRNA-155 binding. J Biol Chem 2007, 282:24262-24269.
61. Baudin B. Polymorphism in angiotensin II receptor genes and hypertension. Exp Physiol 2005, 90:277-282.
62. Bonnardeaux A, Davies E, Jeunemaitre X. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 1994, 24:63-69.
63. Wang WY, Zee RY, Morris BJ. Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension. Clin Genet 1997, 51:31-34.
64. Osterop AP, Kofflard MJ, Sandkuijl LA. AT1 receptor A/C1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy. Hypertension 1998, 32:825-830.
65. Benetos A, Gautier S, Ricard S. Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. Circulation 1996, 94:698-703.
66. Tiret L, Bonnardeaux A, Poirier O. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 1994, 344:910-913.
67. de Gasparo M, Catt KJ, Inagami T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000, 52:415-472.
68. Lv K, Guo Y, Zhang Y. Allele-specific targeting of hsa-miR-657 to human IGF2R creates a potential mechanism underlying the association of ACAA-insertion/deletion polymorphism with type 2 diabetes. Biochem Biophys Res Commun 2008, 374:101-105.
69. Tan Z, Randall G, Fan J. Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am J Hum Genet 2007, 81:829-834.
70. Wang G, van der Walt JM, Mayhew G. Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. Am J Hum Genet 2008, 82:283-289.
71. Jensen KP, Covault J, Conner TS. A common polymorphism in serotonin receptor 1B mRNA moderates regulation by miR-96 and associates with aggressive human behaviors. Mol Psychiatry 2009, 14:381-389.
72. Conner T. Functional polymorphisms in the serotonin 1B receptor gene (HTR1B) predict self-reported anger and hostility among young men. Am J Med Genet B 2009, 153B:67-78.
73. Rademakers R. Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Human Mol Genet 2008, 17:3631-3642.
74. Donner J, Pirkola S, Silander K. An association analysis of murine anxiety genes in humans implicates novel candidate genes for anxiety disorders. Biol Psychiatry 2008, 64:672-680.
75. Chi SW, Zang JB, Mele A. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 2009, 460:479-486.
76. Willenbrock H, Salomon J, Sokilde R. Quantitative miRNA expression analysis: comparing microarrays with next-generation sequencing. RNA 2009, 15:2028-2034.
77. Nam S, Li M, Choi K. MicroRNA and mRNA integrated analysis (MMIA): a web tool for examining biological functions of microRNA expression. Nucleic Acids Res 2009, 37:W356-W362.
78. Nam S, Kim B, Shin S. miRGator: an integrated system for functional annotation of microRNAs. Nucleic Acids Res 2008, 36:D159-D164.